| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |